narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency has…
Browsing: Therapeutics
narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency has…
Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long ago,…
narvikk PTC Therapeutics (NASDAQ:PTCT) is up ~2% in Monday buying and selling after UBS resumed coverage of the inventory with a buy rating. The agency has…
Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha
Eliem Therapeutics (NASDAQ:ELYM) has introduced the appointments of Brett Kaplan as COO and Nishi Rampal as Senior Vice President, Clinical Development. Most not too long ago,…
Altamira Therapeutics extends distribution agreement with Pharma Nordic Source: Seekingalpha
Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha
Altamira Therapeutics extends distribution agreement with Pharma Nordic Source: Seekingalpha
Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q Source: Seekingalpha